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A new dipolarophile used in the construction of bioactive
heterocycles, (Z)-3-(3,4-dimethoxyphenyl)-2-(4-methoxy-
phenyl)acrylonitrile, C18H17NO3, has been synthesized by
base-catalysed reaction of 3,4-dimethoxybenzaldehyde with
(4-methoxyphenyl)acetonitrile. The olefinic bond has Z
geometry and the molecules are linked by C—H  O and
C—H  N hydrogen bonds.
Comment
2,3-Disubstituted acrylonitriles represent an interesting class
of biologically active compounds and are capable of under-
going many useful organic transformations and have been
transformed into bioactive heterocycles (Urska et al., 2003).
Using the nitrile function for C—C bond formation reaction is
very important in organic chemistry (Collier et al., 2004). The
deprotonation of the -carbon and alkylation is an important
reaction (Murahashi et al., 2004). Combretastatin A-4, (II),
shows potent cytotoxicity against a wide variety of human
cancer cell lines, including MDR cancer cell lines (El-Zayat et
al., 1993) and is thus an attractive lead compound for the
development of anticancer drugs. The title compound (I) was
designed as an analog of (II) in which the 3-hydroxy-4-
methoxyphenyl unit was replaced by a 4-methoxyphenyl unit
and olefinic bond carrying nitrile group..
Recently, the crystal structures of some bioactive hetero-
arylacrylonitriles have been reported (Maturana et al., 2005).
It has been found from the literature that the olefinic bond
hase Z geometry, irrespective of the size of the substituents on
the heterocyclic rings (Sonar et al., 2005). The X-ray structure
determination was carried out in order to confirm the olefinic
bond geometry connected to 4-methoxyphenylacetonitrile and
the 3,4-dimethoxyphenyl ring.
The molecular structure and atom-numbering scheme of (I)
are shown in Fig. 1. In (I), the olefinic bond connecting the (4-
methoxyphenyl)acetonitrile and 3,4-dimethoxyphenyl groups
has Z geometry. Significant deviations from the ideal bond-
angle geometry around the Csp2 atoms of the double bond are
observed. The bond angles C13—C12 C9 = 132.13 (19),
C12 C9—C5 = 123.86 and C10—C9—C5 = 114.50 (17) are
distorted due to steric hindrance of the double bond linking
the two ring systems. The olefinic double bond bearing the
three conjugated substituents in (I) has a length of 1.348 (4) A˚,
slightly longer than that observed in (Z)-2-(3-thienyl)-3-(3,4-
dimethoxyphenyl)acrylonitrile [1.353 (3) A˚; Sonar et al., 2005]
and 2-styrylbenzimidazole [1.304 (4) A˚; Bacelo et al., 1997],
suggesting some delocalization of the unsaturated bridging
units. The C18—C13—C12 C9 torsion angle of 169.4 (2)
indicates the deviation of the 3,4-dimethoxyphenyl ring from
the plane of the olefinic double bond.
The structure exhibits intermolecular hydrogen bonds of
the type C—H  O and C—H  N (Table 2), which help to
stabilize the crystal structure. These intermolecular hydrogen
bonds link the molecules into chains (Fig. 2).
Experimental
To a well stirred suspension of 3,4-dimethoxybenzaldehyde (1.13 g,
6.8 mmol) in 5% NaOH (10 ml) solution, was added (4-methoxy-
phenyl)acetonitrile (1 g, 6.8 mmol) along with a catalytic amount of
tert-butylammonium bromide. The mixture was stirred at room
temperature for 45 min, saturated sodium chloride solution (10 ml)
added, and extracted with diethyl ether (3  15 ml). The combined
organic layer was dried over anhydrous sodium sulfate and evapo-
rated under vacuum to obtain a crude mass, which on recrystallization
from methanol gave (I) as a pale-yellow crystalline solid (m.p
383.15 K). Analysis calculated for C18H17NO3: C 73.20; H 5.80, N
4.74%; found: C 73.21, H 5.80, N 4.73%.
Crystal data
C18H17NO3
Mr = 295.33
Monoclinic, P21=c
a = 14.830 (9) A˚
b = 13.688 (7) A˚
c = 7.445 (16) A˚
 = 91.724 (2)
V = 1511 (3) A˚3
Z = 4
Dx = 1.299 Mg m
3
Mo K radiation
 = 0.09 mm1
T = 295 (2) K
Block, pale yellow
0.25  0.20  0.20 mm
Data collection
MacScience DIPLabo 32001
diffractometer
! scans
Absorption correction: none
4731 measured reflections
2549 independent reflections
1955 reflections with I > 2(I)
Rint = 0.019
max = 25.0

Refinement
Refinement on F 2
R[F 2 > 2(F 2)] = 0.054
wR(F 2) = 0.168
S = 1.05
2549 reflections
203 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.1039P)2
+ 0.2197P]
where P = (Fo
2 + 2Fc
2)/3
(/)max < 0.001
max = 0.20 e A˚
3
min = 0.19 e A˚3
Extinction correction: SHELXL97
Extinction coefficient: 0.042 (7)
Table 1
Selected geometric parameters (A˚, ).
O7—C2 1.371 (4)
O7—C8 1.421 (4)
O19—C17 1.368 (4)
O19—C20 1.428 (4)
O21—C16 1.368 (4)
O21—C22 1.425 (4)
N11—C10 1.148 (4)
C2—O7—C8 118.21 (18)
C17—O19—C20 117.06 (17)
C16—O21—C22 116.98 (17)
O7—C2—C1 115.83 (18)
O7—C2—C3 124.77 (18)
N11—C10—C9 176.5 (2)
O21—C16—C15 124.50 (18)
O21—C16—C17 116.14 (17)
O19—C17—C16 115.41 (18)
O19—C17—C18 125.39 (18)
Table 2
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
C12—H12  N11i 0.93 2.62 3.522 (8) 164
C22—H22C  O7ii 0.96 2.55 3.341 (8) 140
Symmetry codes: (i) xþ 1; yþ 12;zþ 12; (ii) xþ 1; y  12;zþ 12.
H atoms were placed at idealized positions and allowed to ride on
their parent atoms, with C—H = 0.92–0.98 A˚ and Uiso(H) = xUeq(C),
where x = 1.5 for methyl H atoms and 1.2 for other H atoms.
Data collection: XPRESS (MacScience, 2002); cell refinement:
SCALEPACK (Otwinowski & Minor, 1997); data reduction:
DENZO (Otwinowski and Minor, 1997) and SCALEPACK;
program(s) used to solve structure: SHELXS97 (Sheldrick, 1997);
program(s) used to refine structure: SHELXL97 (Sheldrick, 1997);
organic papers
o3240 Naveen et al.  C18H17NO3 Acta Cryst. (2006). E62, o3239–o3241
Figure 1
View of (I), with 50% probability displacement ellipsoids.
Figure 2
The crystal packing in (I), viewed down the c axis. Dashed lines indicate
hydrogen bonds.
molecular graphics: PLATON (Spek, 2003) and ORTEPII (Johnson,
1976); software used to prepare material for publication: PLATON.
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